Work

Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma

Year: 2024

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2024.07.156

Authors: A.O. Naghavi, J. Costello, Y. Kim, D. Joyce, K.A. Ahmed, G. Redler, G.Q. Yang, S.A. Rosenberg, J.M. Bryant, M.M. Bui, E.B. Henderson-Jackson, R.J. Gonzalez, O. Binitie, A. Lazarides, J. Mullinax, V. Feygelman, A.F. Ahmed, N. Parikh, J.F. Torres-Roca, K. Latifi

Institution: Moffitt Cancer Center

Language: English

Topic: Radiomics and Machine Learning in Medical Imaging

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Astellas Pharma, Genentech, Daiichi Sankyo Europe

OpenAlex ID: W4402906176

FWCI:

Cites:

Cited by:

Related to: 10